Table of Contents Author Guidelines Submit a Manuscript
Sleep Disorders
Volume 2014, Article ID 518920, 6 pages
http://dx.doi.org/10.1155/2014/518920
Clinical Study

Relationships between Obstructive Sleep Apnea Syndrome, Continuous Positive Airway Pressure Treatment, and Inflammatory Cytokines

1Department of Chest Diseases, Seydişehir State Hospital, 42370 Konya, Turkey
2Department of Chest Diseases, Meram Medical Faculty, Necmettin Erbakan University, 42090 Konya, Turkey
3Department of Chest Diseases, Fatih Sultan Mehmet Education and Research Hospital, 34726 Istanbul, Turkey
4Department of Biochemistry, Konya Education and Research Hospital, 42090 Konya, Turkey

Received 2 February 2014; Accepted 23 March 2014; Published 6 May 2014

Academic Editor: Marco Zucconi

Copyright © 2014 Filiz Ünüvar Doğan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. T. McNicholas, “Obstructive sleep apnea and inflammation,” Progress in Cardiovascular Diseases, vol. 51, no. 5, pp. 392–399, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. E. S. Arnardottir, M. Mackiewicz, T. Gislason, K. L. Teff, and A. I. Pack, “Molecular signatures of obstructive sleep apnea in adults: a review and perspective,” Sleep, vol. 32, no. 4, pp. 447–470, 2009. View at Google Scholar · View at Scopus
  3. S. Ryan, C. T. Taylor, and W. T. McNicholas, “Predictors of elevated nuclear factor-κB-dependent genes in obstructive sleep apnea syndrome,” American Journal of Respiratory and Critical Care Medicine, vol. 174, no. 7, pp. 824–830, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Minoguchi, T. Tazaki, T. Yokoe et al., “Elevated production of tumor necrosis factor-α by monocytes in patients with obstructive sleep apnea syndrome,” Chest, vol. 126, no. 5, pp. 1473–1479, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Minoguchi, T. Yokoe, T. Tazaki et al., “Increased carotid intima-media thickness and serum inflammatory markers in obstructive sleep apnea,” American Journal of Respiratory and Critical Care Medicine, vol. 172, no. 5, pp. 625–630, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. T. U. Ciftci, O. Kokturk, N. Bukan, and A. Bilgihan, “The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome,” Cytokine, vol. 28, no. 2, pp. 87–91, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Liu, J. Liu, S. Xiong, G. Shen, Z. Zhang, and Y. Xu, “The change of interleukin-6 and tumor necrosis factor in patients with obstructive sleep apnea syndrome,” Journal of Tongji Medical University, vol. 20, no. 3, pp. 200–202, 2000. View at Google Scholar · View at Scopus
  8. A. N. Vgontzas, D. A. Papanicolaou, E. O. Bixler, A. Kales, K. Tyson, and G. P. Chrousos, “Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity,” Journal of Clinical Endocrinology and Metabolism, vol. 82, no. 5, pp. 1313–1316, 1997. View at Google Scholar · View at Scopus
  9. G. E. Carpagnano, S. A. Kharitonov, O. Resta, M. P. Foschino-Barbaro, E. Gramiccioni, and P. J. Barnes, “Increased 8-isoprostane and interleukin-6 in breath condensate ofobstructive sleep apnea patients,” Chest, vol. 122, no. 4, pp. 1162–1167, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. T. B. Harris, L. Ferrucci, R. P. Tracy et al., “Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly,” American Journal of Medicine, vol. 106, no. 5, pp. 506–512, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. A. N. Vgontzas, E. Zoumakis, E. O. Bixler et al., “Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 5, pp. 2119–2126, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Minoguchi, T. Tazaki, T. Yokoe et al., “Elevated production of tumor necrosis factor-α by monocytes in patients with obstructive sleep apnea syndrome,” Chest, vol. 126, no. 5, pp. 1473–1479, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Yokoe, K. Minoguchi, H. Matsuo et al., “Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure,” Circulation, vol. 107, no. 8, pp. 1129–1134, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Barceló, F. Barbé, E. Llompart et al., “Effects of obesity on C-reactive protein level and metabolic disturbances in male patients with obstructive sleep apnea,” American Journal of Medicine, vol. 117, no. 2, pp. 118–121, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Imagawa, Y. Yamaguchi, K. Ogawa et al., “Interleukin-6 and tumor necrosis factor-alpha in patients with obstructive sleep apnea-hypopnea syndrome,” Respiration, vol. 71, no. 1, pp. 24–29, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Guilleminault, C. Kirisoglu, and M. M. Ohayon, “C-reactive protein and sleep-disordered breathing,” Sleep, vol. 27, no. 8, pp. 1507–1511, 2004. View at Google Scholar · View at Scopus
  17. M. Kohler, L. Ayers, J. C. T. Pepperell et al., “Effects of continuous positive airway pressure on systemic inflammation in patients with moderate to severe obstructive sleep apnoea: a randomised controlled trial,” Thorax, vol. 64, no. 1, pp. 67–73, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. “Obesity: preventing and managing the global epidemic,” Report of a WHO Consultation 894, World Health Organ Tech Rep Ser 2000.
  19. American Academy of Sleep Medicine, International Classification of Sleep Disorders: Diagnostic and Coding Manual, American Academy of Sleep Medicine, Westchester, Ill, USA, 2nd edition, 2005.
  20. I. Alam, K. Lewis, J. W. Stephens, and J. N. Baxter, “Obesity, metabolic syndrome and sleep apnoea: all pro-inflammatory states,” Obesity Reviews, vol. 8, no. 2, pp. 119–127, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. A. N. Vgontzas, E. Zoumakis, H.-M. Lin, E. O. Bixler, G. Trakada, and G. P. Chrousos, “Marked decrease in sleepiness in patients with sleep apnea by etanercept, a tumor necrosis factor-α antagonist,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 9, pp. 4409–4413, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. A. N. Vgontzas, E. O. Bixler, and G. P. Chrousos, “Metabolic disturbances in obesity versus sleep apnoea: the importance of visceral obesity and insulin resistance,” Journal of Internal Medicine, vol. 254, no. 1, pp. 32–44, 2003. View at Publisher · View at Google Scholar · View at Scopus